A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT05814848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05814848
- Sponsor
- Changhai Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2028-03-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.